本页面由Tiger Trade Technology Pte. Ltd.提供服务

Bausch Health Companies Inc

6.08
-0.0800-1.30%
盘后6.150.0700+1.15%19:38 EST
成交量:254.99万
成交额:1,548.94万
市值:22.53亿
市盈率:6.29
高:6.20
开:6.11
低:5.97
收:6.16
52周最高:8.69
52周最低:4.25
股本:3.71亿
流通股本:1.88亿
量比:1.51
换手率:1.36%
股息:- -
股息率:- -
每股收益(TTM):0.9672
每股收益(LYR):-0.1250
净资产收益率:563.16%
总资产收益率:4.83%
市净率:-3.99
市盈率(LYR):-48.64

数据加载中...

公司资料

公司名字:
Bausch Health Companies Inc
交易所:
NYSE
成立时间:
- -
员工人数:
20700
公司地址:
2150 St. ElzEar Boulevard West,Laval,Quebec,Canada
邮编:
H7L 4A8
电话:
传真:
- -
简介:
Bausch Health Companies Inc.是一家在加拿大不列颠哥伦比亚省注册的公司。该公司是一家跨国、专业制药和医疗器械公司,主要在胃肠病学和皮肤病学的治疗领域开发、制造和销售一系列广泛的品牌、非专利和品牌非专利药品、非处方药产品和医疗美容器械,并通过其对Bausch + Lomb Corporation约89%的所有权,在眼健康治疗领域开发品牌和品牌非专利药品、非处方药产品和医疗器械(隐形眼镜、人工晶状体、眼科手术设备)。该公司的产品直接或间接销往大约100个国家。

董事

名称
职位
John A. Paulson
Chairman of the Board
Thomas J. Appio
Chief Executive Officer and Director
Amy B. Wechsler
Independent Director
Christian A. Garcia
Independent Director
Frank D. Lee
Independent Director
Richard C. Mulligan
Independent Director
Robert N. Power
Independent Director
Sarah B. Kavanagh
Independent Director
Michael Goettler
Director
Sandra Leung
Director

股东

名称
职位
Thomas J. Appio
Chief Executive Officer and Director
Jean Jacques Charhon
Executive Vice President and Chief Financial Officer and Chief Accounting Officer
Steven Lee
Senior Vice President, Controller and Chief Accounting Officer
Aimee J. Lenar
Executive Vice President, US Pharma
Seana Carson
Executive Vice President and General Counsel